[Federal Register Volume 88, Number 225 (Friday, November 24, 2023)]
[Notices]
[Page 82386]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-25885]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Amended 
Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Center for Advancing Translational Sciences Special Emphasis Panel, 
Preclinical Proof of Concept Studies for Rare Diseases (R21) January 
24, 2024, 9:00 a.m. to January 25, 2024, 5:00 p.m., National Institutes 
of Health, National Center for Advancing Translational Sciences, 6701 
Democracy Boulevard, Bethesda, MD, 20892 which was published in the 
Federal Register on November 14, 2023, FR DOC 2023-25070, 88 FR 78052.
    The meeting is being rescheduled due to panel member availability. 
The meeting will be held on February 1, 2024, 9:00 a.m. to February 2, 
2024, 5:00 p.m. This meeting will be held virtually. The meeting is 
closed to the public.

    Dated: November 17, 2023.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-25885 Filed 11-22-23; 8:45 am]
BILLING CODE 4140-01-P